Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugsKASHUBA, A. D. M; NAFZIGER, A. N.Clinical pharmacokinetics. 1998, Vol 34, Num 3, pp 203-218, issn 0312-5963Article

Pharmacologic Opportunities for HIV PreventionNICOL, M. R; KASHUBA, A. D. M.Clinical pharmacology and therapeutics. 2010, Vol 88, Num 5, pp 598-609, issn 0009-9236, 12 p.Article

Legionella urinary antigen testing : Potential impact on diagnosis and antibiotic therapyKASHUBA, A. D. M; BALLOW, C. H.Diagnostic microbiology and infectious disease. 1996, Vol 24, Num 3, pp 129-139, issn 0732-8893Article

Evaluation of the genetic component of variability in CYP3A4 activity : a repeated drug administration methodÖZDEMIR, V; KALOW, W; TANG, B.-K et al.Pharmacogenetics (London). 2000, Vol 10, Num 5, pp 373-388, issn 0960-314XArticle

Development and evaluation of a Bayesian pharmacokinetic estimator and optimal, sparse sampling strategies for ceftazidimeKASHUBA, A. D. M; BALLOW, C. H; FORREST, A et al.Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 8, pp 1860-1865, issn 0066-4804Article

Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organismsKASHUBA, A. D. M; BERTINO, J. S; NAFZIGER, A. N et al.Antimicrobial agents and chemotherapy. 1998, Vol 42, Num 7, pp 1842-1844, issn 0066-4804Article

Limitations of dextromethorphan N-demethylation as a measure of CYP3A activityKASHUBA, A. D. M; NAFZIGER, A. N; KEARNS, G. L et al.Pharmacogenetics (London). 1999, Vol 9, Num 4, pp 453-462, issn 0960-314XArticle

Nucleoside analogues achieve high concentrations in seminal plasma: Relationship between drug concentration and virus burdenPEREIRA, A. S; KASHUBA, A. D. M; FISCUS, S. A et al.The Journal of infectious diseases. 1999, Vol 180, Num 6, pp 2039-2043, issn 0022-1899Article

Antiretroviral-drug concentrations in semen : Implications for sexual transmission of human immunodeficiency virus type 1KASHUBA, A. D. M; DYER, J. R; KRAMER, L. M et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 8, pp 1817-1826, issn 0066-4804Article

Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteriaKASHUBA, A. D. M; NAFZIGER, A. N; DRUSANO, G. L et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 3, pp 623-629, issn 0066-4804Article

Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotypingKASHUBA, A. D. M; NAFZIGER, A. N; KEARNS, G. L et al.Clinical pharmacology and therapeutics. 1998, Vol 64, Num 3, pp 257-268, issn 0009-9236Article

Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjectsHOGELAND, G. W; SWINDELLS, S; MCNABB, J. C et al.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 1, pp 69-75, issn 0009-9236, 7 p.Article

Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolamKASHUBA, A. D. M; BERTINO, J. S; ROCCI, M. L et al.Clinical pharmacology and therapeutics. 1998, Vol 64, Num 3, pp 269-277, issn 0009-9236Article

Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotypingKASHUBA, A. D. M; NAFZIGER, A. N; KEARNS, G. L et al.Pharmacogenetics (London). 1998, Vol 8, Num 5, pp 403-410, issn 0960-314XArticle

Absence of effect of terbinafine on the activity of CYP1A2, NAT-2, and xanthine oxidaseTREPANIER, E. F; NAFZIGER, A. N; KEARNS, G. L et al.Journal of clinical pharmacology. 1998, Vol 38, Num 5, pp 424-428, issn 0091-2700Article

Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotypingKASHUBA, A. D. M; BERTINO, J. S; KEARNS, G. L et al.Clinical pharmacology and therapeutics. 1998, Vol 63, Num 5, pp 540-551, issn 0009-9236Article

Development of an LC―MS Method for Measuring TNF in Human Vaginal TissueCHOI, S. O; REZK, N; KIM, J. S et al.Journal of chromatographic science. 2010, Vol 48, Num 3, pp 219-223, issn 0021-9665, 5 p.Article